Holen Sie sich die Stockscreener-App
1.13
3.66%
0.0399
Handel nachbörslich:
1.13
Schlusskurs vom Vortag:
$1.0901
Offen:
$1.18
24-Stunden-Volumen:
47,431
Relative Volume:
0.18
Marktkapitalisierung:
$3.06M
Einnahmen:
$31,800
Nettoeinkommen (Verlust:
$-37.83M
KGV:
-1.5915
EPS:
-0.71
Netto-Cashflow:
$-30.64M
1W Leistung:
+4.63%
1M Leistung:
-14.39%
6M Leistung:
-97.27%
1J Leistung:
-97.58%
1-Tages-Spanne:
$1.10
$1.18
1-Wochen-Bereich:
$1.0204
$1.18
52-Wochen-Spanne:
$0.85
$124.80
Eyenovia Inc Stock (EYEN) Company Profile
Firmenname
Eyenovia Inc
Sektor
Branche
Telefon
813-766-9539
Adresse
295 MADISON AVENUE,, NEW YORK, NY
Vergleichen Sie EYEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
1.13 | 3.06M | 31,800 | -37.83M | -30.64M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.47 | 125.74B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
599.76 | 61.57B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
600.51 | 36.40B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.61 | 30.36B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
256.16 | 24.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-03-01 | Eingeleitet | Northland Capital | Outperform |
| 2020-02-03 | Herabstufung | Oppenheimer | Outperform → Perform |
Eyenovia Inc Aktie (EYEN) Neueste Nachrichten
Eyenovia Inc reports results for the quarter ended December 31Earnings Summary - TradingView
EYENOVIA, INC. SEC 10-K Report - TradingView
Eyenovia Inc expected to post a loss of $7.20 a shareEarnings Preview - TradingView
Eyenovia (EYEN) Advances with Optejet User Filled Device Development | EYEN Stock News - GuruFocus
Eyenovia Provides Development Update on Optejet User Filled Devi - GuruFocus
Eyenovia nears regulatory submission for Optejet UFD device By Investing.com - Investing.com South Africa
Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - The Manila Times
Eyenovia nears regulatory submission for Optejet UFD device - Investing.com
Eyenovia provides development update on Optejet UFD - TipRanks
Revolutionary Eye Drug Device Passes Critical Tests: Eyenovia's Game-Changing Innovation - Stock Titan
Mydriasis Market Predicted to See Upsurge Through 2034, - openPR.com
Mydriasis Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc., Taejoon Pharma - Barchart.com
Eyenovia Delays Yearly Report Filing - TipRanks
Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq - insights.citeline.com
Eyenovia falls on plans to seek reverse merger - MSN
Eyenovia Enters Into Non-Binding Letter of Intent to Effect Reverse Merger With Betaliq - VisionMonday.com
Eyenovia And Betaliq Announce Potential Reverse Merger - Nasdaq
Eyenovia Shares Drop 14% Amid Betaliq Merger Talks - Yahoo
Eyenovia stock falls on reverse merger plans (EYEN:NASDAQ) - Seeking Alpha
Eyenovia falls after plans to merge with private firm Betaliq - TradingView
Eyenovia Plans All-Stock Reverse Merger With Betaliq - MarketWatch
Eyenovia and Betaliq Explore Merger to Form New Ophthalmic Company Combining Innovative Drug Delivery Technologies for Glaucoma Treatment - Nasdaq
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewswire
Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery - StockTitan
EYENOVIA Earnings Preview: Recent $EYEN Insider Trading, Hedge Fund Activity, and More - Nasdaq
Eyenovia, Inc. to Host Earnings Call - ACCESS Newswire
Eyenovia regains compliance with Nasdaq - MSN
Eyenovia, Inc. (NASDAQ:EYEN) Short Interest Up 346.2% in February - The AM Reporter
Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewswire
Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On? - Benzinga
Eyenovia regains Nasdaq compliance, eyes strategic options By Investing.com - Investing.com Canada
Eyenovia regains Nasdaq compliance, eyes strategic options - Investing.com India
Eyenovia shareholders approve reverse stock split and additional stock reserve - MSN
Eyenovia Escapes Delisting Threat: What's Next for the Optejet Developer? - StockTitan
Eyenovia regains Nasdaq compliance with stock bid price By Investing.com - Investing.com Australia
Eyenovia regains Nasdaq compliance with stock bid price - Investing.com
Eyenovia, Inc. Announces Debt Restructuring, Including Amendment to Senior Secured Debt to Improve Liquidity - Vision Monday
Eyenovia defers debt payments to bolster liquidity By Investing.com - Investing.com Nigeria
Eyenovia announces debt restructuring, improving cash runway - MSN
Eyenovia, Inc. Announces Debt Restructuring Including - GlobeNewswire
Eyenovia defers loan payments, may convert debt to equity By Investing.com - Investing.com Canada
Eyenovia defers loan payments, may convert debt to equity - Investing.com India
Eyenovia defers debt payments to bolster liquidity - Investing.com India
Finanzdaten der Eyenovia Inc-Aktie (EYEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.04%
2.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):